Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics
Abstract Background Speckle-type POZ protein (SPOP) is an E3 ubiquitin ligase adaptor protein that functions as a potential tumor suppressor, and SPOP mutations have been identified in ~10% of human prostate cancers. However, it remains unclear if mutant SPOP proteins can be utilized as biomarkers f...
Main Authors: | Hui Wang, Christopher E. Barbieri, Jintang He, Yuqian Gao, Tujin Shi, Chaochao Wu, Athena A. Schepmoes, Thomas L. Fillmore, Sung-Suk Chae, Dennis Huang, Juan Miguel Mosquera, Wei-Jun Qian, Richard D. Smith, Sudhir Srivastava, Jacob Kagan, David G. Camp, Karin D. Rodland, Mark A. Rubin, Tao Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-017-1276-7 |
Similar Items
-
SPOP the mutation
by: Leah Rider, et al.
Published: (2015-10-01) -
SPOP mutation leads to genomic instability in prostate cancer
by: Gunther Boysen, et al.
Published: (2015-09-01) -
The emerging role of SPOP protein in tumorigenesis and cancer therapy
by: Yizuo Song, et al.
Published: (2020-01-01) -
The SPOP-ITCH Signaling Axis Protects Against Prostate Cancer Metastasis
by: Jinlu Ma, et al.
Published: (2021-07-01) -
SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair
by: Rihan El Bezawy, et al.
Published: (2020-06-01)